Short-course hormonal therapy and the risk of death from prostate cancer in men with intermediate-risk prostate cancer undergoing high-dose radiation therapy

被引：0
|
作者：
Keane, Florence K.
Chen, Ming-Hui
Zhang, Danjie
Moran, Brian Joseph
Braccioforte, Michelle H.
D'Amico, Anthony Victor
机构：
[1] Brigham & Womens Hosp, Harvard Radiat Oncol Program, Boston, MA 02115 USA
[2] Univ Connecticut, Storrs, CT USA
[3] Prostate Canc Fdn Chicago, Westmont, IL USA
[4] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.27
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
27
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Personalizing the Management of Men with Intermediate-risk Prostate Cancer
    D'Amico, Anthony V.
    EUROPEAN UROLOGY, 2013, 64 (06) : 903 - 904
  • [42] Intermediate-risk profile in prostate cancer. Role of combined radiation and hormone therapy
    Beck, Marcus
    Boehmer, Dirk
    Hoecht, Stefan
    Zschaeck, Sebastian
    Budach, Volker
    Wiegel, Thomas
    Ghadjar, Pirus
    ONKOLOGE, 2019, 25 (04): : 322 - 329
  • [43] Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
    Cagney, Daniel N.
    Dunne, Mary
    O'Shea, Carmel
    Finn, Marie
    Noone, Emma
    Sheehan, Martina
    McDonagh, Lesley
    O'Sullivan, Lydia
    Thirion, Pierre
    Armstrong, John
    BMC UROLOGY, 2017, 17
  • [44] Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
    Daniel N. Cagney
    Mary Dunne
    Carmel O’Shea
    Marie Finn
    Emma Noone
    Martina Sheehan
    Lesley McDonagh
    Lydia O’Sullivan
    Pierre Thirion
    John Armstrong
    BMC Urology, 17
  • [45] Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy
    Karlsdottir, Asa
    Muren, Ludvig Paul
    Wentzel-Larsen, Tore
    Johannessen, Dag C.
    Haukaas, Svein Andreas
    Halvorsen, Ole Johan
    Dahl, Olav
    ACTA ONCOLOGICA, 2009, 48 (06) : 874 - 881
  • [46] Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer Statement from the DEGRO working group on prostate cancer
    Beck, Marcus
    Boehmer, Dirk
    Aebersold, Daniel M.
    Albrecht, Clemens
    Flentje, Michael
    Ganswindt, Ute
    Hoecht, Stefan
    Hoelscher, Tobias
    Mueller, Arndt-Christian
    Niehoff, Peter
    Pinkawa, Michael
    Sedlmayer, Felix
    Zips, Daniel
    Zschaeck, Sebastian
    Budach, Volker
    Wiegel, Thomas
    Ghadjar, Pirus
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (02) : 109 - 116
  • [47] TESTOSTERONE THERAPY AFTER RADIATION THERAPY FOR LOW, INTERMEDIATE, AND HIGH RISK PROSTATE CANCER
    Pastuszak, A. W.
    Khanna, A.
    Badhiwala, N.
    Morgentaler, A.
    Hulth, M.
    Conners, W. P.
    Sarosdy, M.
    Carrion, R.
    Lipshultz, L., I
    Khera, M.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 119 - 119
  • [48] Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer
    Pastuszak, Alexander W.
    Khanna, Abhinav
    Badhiwala, Niraj
    Morgentaler, Abraham
    Hult, Mariam
    Conners, William P.
    Sarosdy, Michael F.
    Yang, Christopher
    Carrion, Rafael
    Lipshultzk, Larry I.
    Khera, Mohit
    JOURNAL OF UROLOGY, 2015, 194 (05): : 1271 - 1276
  • [49] Radiation treatment for patients with intermediate-risk prostate cancer
    Greene, David E.
    Mayadev, Jyoti S.
    Valicenti, Richard K.
    THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (03) : 113 - 124
  • [50] Optimizing the use of androgen deprivation therapy in men with localized intermediate-risk prostate cancer in the era of modern dose-escalated radiation therapy.
    Patel, Sagar Anil
    Nguyen, Kevin H.
    Lee, Alan K.
    Demanes, David Jeffrey
    Chang, Albert
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
12345